Histopathology Services Market

Report Overview

The global histopathology services market was valued at US$ 34,999.5 million in 2021, and is expected to witness a CAGR of 5.4% during the forecast period from 2022 to 2030.

Market Fundamentals 

Histopathology is the study of disease symptoms through microscopic inspection of a biopsy or surgical specimen that has been processed and put onto glass slides. The slices are stained with one or more dyes to visualize distinct components of the tissue under a microscope. The histopathology services provide a detailed evaluation of the tissue organization at all levels, from the entire organ down to the molecular components of cells.

[302785]

Market Dynamics

The global histopathology market is expected to experience steady growth during the forecasted timeframe. Preliminary diagnoses of medical indication are growing due to growing clinical trials and proving a major driving factor. The growth of this market is also influenced by rapidly growing cases of cancer and tissue abnormalities among people across the globe and enhancing the demands for histopathology services, thus, boosting the market development. According to a WHO report, nearly 10 million cancer-related deaths were recorded in 2020, resulting in the leading cause of death in the world. Additionally, increasing implantation procedures among people due to various factors such as accidents, age, and others contribute to the market’s expansion. This technology plays a major role in evaluating implanted medical devices (artificial cartilages, hip and knee prostheses, fusion polymers, stents, etc.) to understand their structural functionalities.

Furthermore, factors such as rising demand for biologics also influence the growth of the histopathology services market. For instance, histopathology is employed in nonclinical biomarker qualification investigations to demonstrate correlative and temporal correlations between the biomarker and morphologic alterations. However, limitations associated with histopathology are expected to hamper the market growth.

Market Ecosystem

The global histopathology services market has been analyzed from three perspectives: Application, End-user, And Region

Histopathology Services Market by Application

[7463523]

Based on the application, the global histopathology services market has been divided into skin tissue biopsy, liver biopsy, surgical specimen, breast biopsy, gastrointestinal biopsy, biopsy of gynecological cancers, lung biopsy, testicular biopsy, pancreatic biopsy, and others. Surgical specimen segment dominated the market with the largest revenue share in 2021. Growing cases of abnormalities in the tissues thus, enhancing the therapeutic surgical removal (sample of the tissue) of diseases area or organs are the major driving factors of this segment. Thus, these factors are responsible for the growing demand for effective diagnosis technology. As histopathology is a crucial part of the diagnosis procedure to provide a specified and detailed analysis of removed tissue lump from the diseased region for better treatment, thereby propelling overall market development.

While the breast biopsy segment is estimated to illustrate lucrative growth during the forecast period. An exponential growth of breast-related problems and major breast lumps and breast cancer among a large number of women across the globe is the influencing factor for this lucrative growth. Approximately 2.3 million women were diagnosed with breast cancer, with a total of 6,85,000 deaths globally in 2020, according to the statistics provided the WHO. Thus, positively impacting the overall growth of the histopathology services market.  

Histopathology Services Market by End-user

According to end-user, the global histopathology services market is classified into diagnostic laboratories & reference laboratories, research institutes, and others. Histopathology services are widely used to diagnose many cancer/chronic diseases. Cells and tissues are extracted from anomalous lump regions in order to discover abnormalities and cancer. They are commonly used for cancer screening, including breast, bowel, and cervical cancer, thus, increasing demand for diagnostics and thereby surging the market growth.

Histopathology Services Market by Region

The global histopathology services market has been segmented based on regions into North America, Europe, Asia Pacific, and the rest of the world. Among other regions, North America is the largest shareholder in the global histopathology market. A large base of patients with chronic diseases and increased demand for biologics highly influences the market growth in this region. The ongoing competition within pharmaceutical and biopharmaceutical industries for enhanced biological products and biosimilars. As expert histopathologists contributions have a critical role in understanding tumor biology as well as the harmful mechanisms of numerous bacteria, thus enhancing the overall histopathology services demand in this region. 

While Europe is the second largest stakeholder in the global histopathology services market, mainly owing to large cancer cases and growing research activities. Technological advancements in histopathology services and an increase in funding for different research activities and diagnostic tests also encourage market growth. Additionally, the rise in demand for sophisticated tools for histopathology services in healthcare to improve efficiency and the surge in demand for tailored treatment drive market expansion. Furthermore, the European Commission Health Program cancer project's idea and financial efforts have increased the need for histopathology services. A common EU (European Union) strategy for cancer was introduced, together with a large budget, with the goal of assisting Member States in their battle against the illness. The “Beating Cancer Plan” was supported with € 4 billion in financing by European Commissioner for Health and Food Safety to make a significant difference in the areas of prevention, detection and early diagnosis, treatment, and survivorship of cancer over the next few decades.

Competitive Landscape

The prominent players operating in the global histopathology services market are: 

• Cellular Pathology Services Limited
• Acculabs Diagnostics UK Ltd.
• Great Ormond Street Hospital (GOSH) Laboratory
• HCA Laboratories UK
• Sonic Healthcare Limited
• Targos Molecular Pathology GmbH
• Laboratoire Cerba
• Spire Healthcare Group Plc
• TPL Path Labs
• Unilabs Group Services

Competitive Landscape

• In February 2021, Hologic Inc. announced its strategic partnership with Google Cloud to use machine learning capabilities in its Genius Digital Diagnostics System. This collaboration aims to improve cervical cancer screening using machine learning and artificial intelligence (AI). 
• In September 2020, Cernostics announced its strategic collaboration with Deciphex to assess the application of AI-driven image analysis tools and technology to improve cancer detection in patients with Barrett's Esophagus. This cooperation combines both firms' technology resources, which will be applied to one of the world's biggest databases of thoroughly annotated histological photos of esophageal tissue from Barrett's Esophagus patients. 

Frequently Asked Questions About This Report